These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2946261)

  • 1. The role of immune complexes in the pathogenesis of bacterial infections.
    Høiby N; Döring G; Schiøtz PO
    Annu Rev Microbiol; 1986; 40():29-53. PubMed ID: 2946261
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathogenic mechanisms of chronic Pseudomonas aeruginosa infections in cystic fibrosis patients.
    Høiby N; Döring G; Schiøtz PO
    Antibiot Chemother (1971); 1987; 39():60-76. PubMed ID: 3118792
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipopolysaccharide is present in immune complexes isolated from sputum in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
    Kronborg G; Shand GH; Fomsgaard A; Høiby N
    APMIS; 1992 Feb; 100(2):175-80. PubMed ID: 1554493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating immune complexes in cystic fibrosis.
    Manthei U; Taussig LM; Beckerman RC; Strunk RC
    Am Rev Respir Dis; 1982 Aug; 126(2):253-7. PubMed ID: 7103251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple method to quantitate circulating immune complexes in different diseases.
    Jayapal N; Shanmugasundaram N; Thomas PA; Valli PR; Thyagarajan SP; Subramanian S
    Indian J Pathol Microbiol; 1989 Jan; 32(1):33-9. PubMed ID: 2512253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Glomerulonephritis in infectious endocarditis].
    Diadyk AI; Vasilenko IV; Tsyba IN; Shpilevaia NI; Khomenko MV
    Revmatologiia (Mosk); 1989; (3):29-36. PubMed ID: 2532778
    [No Abstract]   [Full Text] [Related]  

  • 7. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
    Kronborg G
    APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey.
    Hoiby N
    Acta Pathol Microbiol Scand Suppl; 1977; (262):1-96. PubMed ID: 411327
    [No Abstract]   [Full Text] [Related]  

  • 9. Pseudomonas aeruginosa and cystic fibrosis: unusual bacterial adaptation and pathogenesis.
    Govan JR; Harris GS
    Microbiol Sci; 1986 Oct; 3(10):302-8. PubMed ID: 3155268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immune complexes in the pathogenesis of bacterial infections (a review of the literature)].
    Bala MA
    Vrach Delo; 1989 Nov; (11):5-10. PubMed ID: 2692291
    [No Abstract]   [Full Text] [Related]  

  • 11. Local humoral immunity and immune reactions in the lungs of patients with cystic fibrosis.
    Schiøtz PO
    Acta Pathol Microbiol Scand Suppl; 1981; 276():1-25. PubMed ID: 6951389
    [No Abstract]   [Full Text] [Related]  

  • 12. Study of IgG antibodies to Pseudomonas aeruginosa in early cystic fibrosis infection.
    Giordano A; Magni A; Filadoro F; Graziani C; Quattrucci S; Cipriani P
    New Microbiol; 1998 Oct; 21(4):375-8. PubMed ID: 9812319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elastase from polymorphonuclear leucocytes: a regulatory enzyme in immune complex disease.
    Döring G; Goldstein W; Botzenhart K; Kharazmi A; Schiøtz PO; Høiby N; Dasgupta M
    Clin Exp Immunol; 1986 Jun; 64(3):597-605. PubMed ID: 2947759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the relation between the clinical pulmonary condition of children with cystic fibrosis and the lymphoblastic response to the antigen Pseudomonas aeruginosa.
    Van Geffel R; Hubert E; Josse M
    Ann Immunol (Paris); 1982; 133D(3):293-303. PubMed ID: 7165280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiovascular lesions in infectious diseases].
    Totolian AA; Burova LA; Nagornev VA; Pigarevskiĭ PV; Shalen K
    Vestn Ross Akad Med Nauk; 2003; (12):56-61. PubMed ID: 14724975
    [No Abstract]   [Full Text] [Related]  

  • 16. Pseudomonas aeruginosa and Burkholderia cenocepacia infections in patients affected by cystic fibrosis: serum resistance and antibody response.
    Savoia D; Deplano C; Zucca M
    Immunol Invest; 2008; 37(1):19-27. PubMed ID: 18214797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating immune complexes, antibodies to Pseudomonas aeruginosa, and pulmonary status in cystic fibrosis.
    Lagacé J; Mercier J; Fréchette M; Fournier D; Dubreuil M; Lamarre A; Lapointe JR; Montplaisir S
    J Clin Lab Immunol; 1989 Sep; 30(1):7-11. PubMed ID: 2534928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptors in the host defense against Pseudomonas aeruginosa respiratory infection and cystic fibrosis.
    McIsaac SM; Stadnyk AW; Lin TJ
    J Leukoc Biol; 2012 Nov; 92(5):977-85. PubMed ID: 22892106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary infection and antibiotic treatment in patients with cystic fibrosis.
    Kerrebijn KF; Mouton J
    Acta Univ Carol Med (Praha); 1990; 36(1-4):28-33. PubMed ID: 2130712
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation and clinical significance of circulating immune complexes.
    Theofilopoulos AN
    Prog Clin Immunol; 1980; 4():63-106. PubMed ID: 6247742
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.